Crossref journal-article
Springer Science and Business Media LLC
Nature Reviews Drug Discovery (297)
Bibliography

LaMattina, J. L. (2011). The impact of mergers on pharmaceutical R&D. Nature Reviews Drug Discovery, 10(8), 559–560.

Authors 1
  1. John L. LaMattina (first)
References 3 Referenced 90
  1. Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Rev. Drug Discov. 9, 203–214 (2010). (10.1038/nrd3078) / Nature Rev. Drug Discov. by SM Paul (2010)
  2. Garnier, J.-P. Rebuilding the R&D engine in Big Pharma. Harvard Bus. Rev. 86, 68–76 (2008). / Harvard Bus. Rev. by J-P Garnier (2008)
  3. Munos, B. Lessons from 60 years of pharmaceutical innovation. Nature Rev. Drug Discov. 8, 959–968 (2009). (10.1038/nrd2961) / Nature Rev. Drug Discov. by B Munos (2009)
Dates
Type When
Created 14 years, 1 month ago (Aug. 1, 2011, 5:38 a.m.)
Deposited 2 years, 3 months ago (May 19, 2023, 12:07 a.m.)
Indexed 3 days, 20 hours ago (Sept. 3, 2025, 5:53 a.m.)
Issued 14 years, 1 month ago (Aug. 1, 2011)
Published 14 years, 1 month ago (Aug. 1, 2011)
Published Online 14 years, 1 month ago (Aug. 1, 2011)
Published Print 14 years, 1 month ago (Aug. 1, 2011)
Funders 0

None

@article{LaMattina_2011, title={The impact of mergers on pharmaceutical R&D}, volume={10}, ISSN={1474-1784}, url={http://dx.doi.org/10.1038/nrd3514}, DOI={10.1038/nrd3514}, number={8}, journal={Nature Reviews Drug Discovery}, publisher={Springer Science and Business Media LLC}, author={LaMattina, John L.}, year={2011}, month=aug, pages={559–560} }